Working to Eradicate Gynecologic Cancers

Theresa L. Werner, MD

MD
University of Utah, Huntsman Cancer Institute
University of Utah, Huntsman Cancer Institute
2000 Circle of Hope
Salt Lake City, UT
USA 84112

Papers:
53 A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study